Prebiopsy MRI and MRI-ultrasound Fusion-targeted Prostate Biopsy in Men With Previous Negative Biopsies: Impact on Repeat Biopsy Strategies.

[1]  C. Roehrborn,et al.  Decision analysis model comparing cost of multiparametric magnetic resonance imaging vs. repeat biopsy for detection of prostate cancer in men with prior negative findings on biopsy. , 2015, Urologic oncology.

[2]  Samir S Taneja,et al.  Patterns of repeat prostate biopsy in contemporary clinical practice. , 2015, The Journal of urology.

[3]  L. Kavoussi,et al.  In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12‐core biopsy still necessary in addition to a targeted biopsy? , 2015, BJU international.

[4]  Baris Turkbey,et al.  Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. , 2015, JAMA.

[5]  Heinz-Peter Schlemmer,et al.  Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance. , 2015, The Journal of urology.

[6]  Nathan Lawrentschuk,et al.  The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review , 2014, European urology.

[7]  M. Stifelman,et al.  A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. , 2014, European urology.

[8]  M. Roethke,et al.  Evolution of repeat prostate biopsy strategies incorporating transperineal and MRI–TRUS fusion techniques , 2014, World Journal of Urology.

[9]  Baris Turkbey,et al.  Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy. , 2014, The Journal of urology.

[10]  Shyam Natarajan,et al.  Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. , 2014, European urology.

[11]  Jurgen J Fütterer,et al.  Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis. , 2014, AJR. American journal of roentgenology.

[12]  M. Roethke,et al.  Histology core‐specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate , 2013, BJU international.

[13]  U. Patel.  Histology core‐specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate , 2013, BJU international.

[14]  J. Babb,et al.  Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. , 2013, Radiology.

[15]  Baris Turkbey,et al.  Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. , 2013, European urology.

[16]  J. Babb,et al.  Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI. , 2013, AJR. American journal of roentgenology.

[17]  H. Ahmed,et al.  Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer. , 2013, The Journal of urology.

[18]  P. Mozer,et al.  Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. , 2012, European urology.

[19]  H. Hricak,et al.  Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer. , 2012, The Journal of urology.

[20]  J. Kim,et al.  Magnetic resonance imaging targeted biopsy in men with previously negative prostate biopsy results. , 2012, Journal of endourology.

[21]  Christopher J Kane,et al.  Are repeat prostate biopsies safe? A cohort analysis from the SEARCH database. , 2012, The Journal of urology.

[22]  Thomas Hambrock,et al.  Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. , 2010, The Journal of urology.

[23]  H. Hricak,et al.  Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer , 2010, European Radiology.

[24]  M. Barry,et al.  Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. , 2007, Journal of the National Cancer Institute.

[25]  Michael W Kattan,et al.  Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate. , 2006, The Journal of urology.

[26]  M. Cooperberg,et al.  The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. , 2005, The Journal of urology.

[27]  D. Miglioretti,et al.  Physician predictors of mammographic accuracy. , 2005, Journal of the National Cancer Institute.

[28]  Emily F Conant,et al.  Association of volume and volume-independent factors with accuracy in screening mammogram interpretation. , 2003, Journal of the National Cancer Institute.

[29]  P. Walsh,et al.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. , 1994, JAMA.